Briefly summarized, embodiments disclosed herein are directed to fluid path optimization in catheter insertion systems, and associated methods thereof. When placing elongate catheters, such as central venous catheters (CVC), rapid insertion central catheters (RICC), or the like, advanced insertion systems are desirable. These insertion systems can include housings, needles, guidewires, dilators, or blood flash indicators configured to access the vasculature, confirm correct vascular access, dilate the insertion site and place the catheter. Advantageously, the insertion systems can contain the above structures within an enclosed environment to reduce the repeated insertion and removal of multiple devices, and mitigate the introduction of pathogens.
The sequential nature of the tools within these insertion systems can result in a long and convoluted pathways for the blood flow before reaching the blood flash indicator. For example, a needle disposed within a lumen of the catheter, requires blood to flow to at least a proximal end of the catheter before exiting and being observed. Further, blood flash indicators can be situated towards a distal end of the insertion device, proximate the insertion site for ease of observation. As such the blood flow would have to travel twice the length of the catheter before being observed.
Such elongate flow pathways can lead to various problems. For example, the longer flow path requires increased volumes of blood to flow through the system before reaching the blood flash indicator and being observed. Such elongate flow paths can obscure the nature of the pulsatile flow, obfuscating the difference between arterial or venous flow. The delay caused by the increase travel time can lead to a user continuing with insertion despite having accessed the vasculature, resulting in “backwalling” the vessel, i.e. inserting the needle through a far wall of the vessel. Where blood flash systems include a vacuum to draw the blood flow, the convoluted flow path can reduce or compromise the force of the vacuum. Lastly, elongate blood flow pathways can have an increased risk of the blood clotting prior to reaching the blood flash indicator. Embodiments disclosed herein are directed to resolving the aforementioned problems.
Disclosed herein is a catheter insertion system including, a catheter defining a catheter lumen and extending along a longitudinal axis, a needle defining a needle lumen and disposed within a portion of the catheter lumen, a housing supporting one of the catheter or the needle, and a blood flash indicator in fluid communication with the needle lumen, the blood flash indicator including a plunger fixedly attached to the housing and a syringe barrel slidably engaged with the plunger along the longitudinal axis.
In some embodiments, the syringe barrel is configured to slide proximally relative to one of the plunger or the housing to create a vacuum and draw a blood flow through the needle lumen and into the syringe barrel. The syringe barrel is formed of a transparent material to allow for observation of a blood color or pulsatile flow. The syringe barrel is supported by a cradle including a gripping feature and configured to facilitate sliding of the syringe barrel along the longitudinal axis. The housing includes a needle interface defining a needle channel and a blood flash channel, the needle channel configured to receive a portion of the needle extending therethrough and the blood flash channel providing fluid communication between the needle channel and the syringe barrel.
In some embodiments, the needle includes a notch extending through a wall of the needle to provide fluid communication between the needle lumen and the needle channel. The needle channel includes a first O-ring disposed annularly about the needle and disposed distally of the needle notch, and a second O-ring disposed annularly about the needle and disposed proximally of the needle notch, the first O-ring and the second O-ring each extending between an outer surface of the needle and an inner surface of the needle channel to provide a fluid-tight seal therebetween. The needle is slidably engaged with the needle channel. In some embodiments, a portion of the blood flash channel is formed of a flexible tube. The catheter is a central venous catheter or a rapid insertion central catheter.
Also disclosed is a method placing a catheter including, accessing a vasculature with a needle, defining a needle lumen and supported by a housing, sliding a syringe barrel proximally along a longitudinal axis relative to the housing, creating a vacuum within the syringe barrel, and drawing a blood flow through the needle lumen and into the syringe barrel.
In some embodiments, the method further includes a plunger slidably engaged with the syringe barrel, the plunger fixedly attached to the housing to prevent any relative longitudinal movement therebetween. In some embodiments, the method further includes a cradle coupled with the syringe barrel and including a gripping feature. In some embodiments, the method further includes observing a blood flow color or pulsatile flow within the syringe barrel, the syringe barrel formed of a transparent material. In some embodiments, the housing includes a needle interface defining a needle channel and a blood flash channel, the needle channel configured to receive a portion of the needle extending therethrough and the blood flash channel providing fluid communication between the needle channel and the syringe barrel. The needle includes a notch extending through a wall of the needle to provide fluid communication between the needle lumen and the needle channel.
In some embodiments, the needle channel includes a first O-ring disposed annularly about the needle and disposed distally of the needle notch, and a second O-ring disposed annularly about the needle and disposed proximally of the needle notch, the first O-ring and the second O-ring each extending between an outer surface of the needle and an inner surface of the needle channel to provide a fluid-tight seal therebetween. The needle is slidably engaged with the needle channel. In some embodiments, a portion of the blood flash channel is formed of a flexible tube. The catheter is a central venous catheter or a rapid insertion central catheter.
Also disclosed is a catheter placement system including, a catheter defining a catheter lumen and extending along a longitudinal axis, a needle defining a needle lumen and extending through a portion of the catheter lumen, a housing supporting one or both of the catheter and the needle, and including a needle interface piece to provide fluid communication between the needle lumen and a blood flash channel, and a blood flash indicator in fluid communication with the blood flash channel at a point distal of a proximal end of the needle, the blood flash indicator including a syringe barrel fixedly attached to the housing and a plunger slidably engaged with the syringe barrel between proximal position and a distal position.
In some embodiments, the plunger is configured to slide from the proximal position to the distal position to create a vacuum within the syringe barrel. The needle interface piece defines a needle channel communicating with the blood flash channel, the needle channel configured to receive a portion of the needle extending therethrough. The needle includes a notch extending through a wall of the needle to provide fluid communication between the needle lumen and the needle channel. The needle channel includes a first O-ring disposed annularly about the needle and disposed distally of the needle notch, and a second O-ring disposed annularly about the needle and disposed proximally of the needle notch, the first O-ring and the second O-ring each extending between an outer surface of the needle and an inner surface of the needle channel to provide a fluid-tight seal therebetween. The needle is slidably engaged with the needle channel. In some embodiments, a portion of the blood flash channel is formed of a flexible tube. The catheter is a central venous catheter or a rapid insertion central catheter.
A more particular description of the present disclosure will be rendered by reference to specific embodiments thereof that are illustrated in the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope. Example embodiments of the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:
Before some particular embodiments are disclosed in greater detail, it should be understood that the particular embodiments disclosed herein do not limit the scope of the concepts provided herein. It should also be understood that a particular embodiment disclosed herein can have features that can be readily separated from the particular embodiment and optionally combined with or substituted for features of any of a number of other embodiments disclosed herein.
Regarding terms used herein, it should also be understood the terms are for the purpose of describing some particular embodiments, and the terms do not limit the scope of the concepts provided herein. Ordinal numbers (e.g., first, second, third, etc.) are generally used to distinguish or identify different features or steps in a group of features or steps, and do not supply a serial or numerical limitation. For example, “first,” “second,” and “third” features or steps need not necessarily appear in that order, and the particular embodiments including such features or steps need not necessarily be limited to the three features or steps. Labels such as “left,” “right,” “top,” “bottom,” “front,” “back,” and the like are used for convenience and are not intended to imply, for example, any particular fixed location, orientation, or direction. Instead, such labels are used to reflect, for example, relative location, orientation, or directions. Singular forms of “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise.
With respect to “proximal,” a “proximal portion” or a “proximal end portion” of, for example, a catheter disclosed herein includes a portion of the catheter intended to be near a clinician when the catheter is used on a patient. Likewise, a “proximal length” of, for example, the catheter includes a length of the catheter intended to be near the clinician when the catheter is used on the patient. A “proximal end” of, for example, the catheter includes an end of the catheter intended to be near the clinician when the catheter is used on the patient. The proximal portion, the proximal end portion, or the proximal length of the catheter can include the proximal end of the catheter; however, the proximal portion, the proximal end portion, or the proximal length of the catheter need not include the proximal end of the catheter. That is, unless context suggests otherwise, the proximal portion, the proximal end portion, or the proximal length of the catheter is not a terminal portion or terminal length of the catheter.
With respect to “distal,” a “distal portion” or a “distal end portion” of, for example, a catheter disclosed herein includes a portion of the catheter intended to be near or in a patient when the catheter is used on the patient. Likewise, a “distal length” of, for example, the catheter includes a length of the catheter intended to be near or in the patient when the catheter is used on the patient. A “distal end” of, for example, the catheter includes an end of the catheter intended to be near or in the patient when the catheter is used on the patient. The distal portion, the distal end portion, or the distal length of the catheter can include the distal end of the catheter; however, the distal portion, the distal end portion, or the distal length of the catheter need not include the distal end of the catheter. That is, unless context suggests otherwise, the distal portion, the distal end portion, or the distal length of the catheter is not a terminal portion or terminal length of the catheter.
To assist in the description of embodiments described herein, as shown in
The catheter 120 can be a central venous catheter (CVC), a rapid insertion central catheter (RICC), or similar elongate catheter configured to provide access to a vasculature of a patient. As shown in
The access section 162 can define a single lumen and can be formed of a harder durometer material relative to the catheter body section 166. The catheter body section 166 can define one or more lumen and can be formed of a softer, more compliant material relative to the access section 162. The dilation section 164 can be formed of either the same material as the access section 162, or of a third material. The third material can be of a harder durometer relative to the material of the catheter body section 166. The dilation section 164 can provide a tapered transition between the first diameter of the access section 162 and the second diameter of the catheter body section 166. The access section 162 and the dilation section 164 can provide relatively more rigid mechanical properties and can be relatively more resistant to kinking or collapsing when an axial force is applied thereto, relative to the catheter body section 166. The catheter body section 166 can be relatively more compliant to facilitate negotiating tortuous vascular pathways. In an embodiment, the catheter 120 can further include a hub 168, a bifurcation 170, and/or one or more extension legs 172 each communicating with a lumen of the catheter 120. In an embodiment, the needle 110 can extend through an extension leg 172, through a lumen of the catheter body section 166 and through a lumen of the access section 162 to extend distally of a distal tip of the catheter 120.
In use, a clinician can access a vasculature using the RICC catheter 120 by insertion a needle tip 116 and a distal portion of the access section 162 into a vasculature. A blood flow can flow proximally through the needle lumen 114 to a blood flash indicator 150. A color and pulsatile flow can be observed to confirm correct vascular access. In case of incorrect vascular access, the access section 162 can be withdrawn and the insertion site closed by applying pressure, due to the relatively small diameter of the access section 162. Where correct vascular access is confirmed, the catheter 120 can be advanced, optionally over a guidewire, until a dilation section 164 enters the insertion site and dilates the insertion site to the second diameter of the catheter body section 166. The catheter body section 166 can then be advanced until a distal portion of the catheter 120 is at a target location within the vasculature. Further details of RICC catheters, associated insertion systems and associate methods thereof can be found in U.S. Pat. No. 10,376,675; U.S. Patent Publications U.S. 2019/0255294, U.S. 2021/0069471, U.S. 2021/0085927, U.S. 2021/0113809, U.S. 2021/0113810, U.S. 2021/0121661, U.S. 2021/0121667, U.S. 2021/0228843, U.S. 2021/0322729, U.S. 2021/0330941, U.S. 2021/0330942, and U.S. 2021/0361915, each of which are incorporated by reference in its entirety into this application.
As will be appreciated, depending on the configuration of the catheter insertion system, a blood flash flow would have to travel through the needle lumen 114, from a needle tip 116, substantially to a proximal end of the catheter 120 before exiting the catheter 120 and flowing distally to a blood flash indicator. Embodiments disclosed herein are directed to reducing the distance of travel between the needle tip 116 and the blood flash indicator 150.
In embodiments where the blood flash indicator is disposed towards the distal end of the device, the fluid path can be reduced by positioning the blood flash indicator 150 proximally. More specifically by placing the blood flash indicator 150 proximally of the catheter 120 center-of-mass, the length of the blood flash fluid path can reduced by between 20%-30%.
In an embodiment, as shown in
The needle interface 140 can define a needle channel 142 extending along a longitudinal axis and configured to receive a portion of the needle 110 therethrough. The needle 110 can be slidably engaged with the needle channel 142. The needle interface 140 can further include one or more O-rings 144 extending annularly about the needle 110 and disposed between an outer surface of the needle 110 and an inner surface of the channel 142, to provide a fluid tight seal therebetween.
The needle interface 140 can further include a blood flash channel 152 communicating between the needle channel 142 and the blood flash indicator 150. The blood flash channel 152 can extend substantially perpendicular from the needle channel 142 before extending towards the blood flash indicator 150. Prior to use, the needle notch 118 can be disposed within the needle channel 142, between a first O-ring 144A and a second O-ring 144B, and align with the blood flash channel 152. As the needle tip 116 is advanced into a vasculature, a blood flow can flow proximally through the needle lumen 114 through the notch 118 and into the blood flash channel 152 to the blood flash indicator 150. The first O-ring 144A and the second O-ring 144B can prevent a fluid flow from leaking between an outer surface of the needle 110 and an inner surface of the needle channel 142. The blood flow color or pulsatile flow can be observed to confirm correct vascular access. The needle 110 can then be withdrawn proximally through the needle channel 142 and, optionally, removed. In an embodiment, a portion of the needle 110 that is distal of the needle notch 118 can occlude the opening of the blood flash channel 152 with the needle channel 142 to seal the fluid therein.
In an embodiment, the blood flash indicator 150 can include a container configured to receive a blood flow therein. The container can be formed of a transparent material to allow a user to observe a color and pulsatile flow disposed therein. In an embodiment, the blood flash indicator 150 can include a vacutainer configured to maintain a vacuum therein to facilitate drawing a blood flow proximally through the needle lumen 114, through the needle notch 118, and into the vacutainer. In an embodiment, the vacuum can be maintained within the vacutainer by a portion of the needle 110 occluding the blood flash channel 152. When a user is ready to check for vascular access, the needle 110 can be advanced, relative to the housing 130, until the needle hub 112 abuts against the housing 130 and aligns the needle notch 118 with the blood flash channel 152. As such, the vacuum of the vacutainer is then placed in fluid communication with the needle lumen 114 and can facilitate drawing a blood flow proximally through the needle lumen 114.
In an embodiment, the blood flash indicator 150 can include a syringe barrel 154 and a plunger 156, slidably engaged therewith and configured to create a vacuum to draw a blood flow proximally through the needle lumen 114 and into the syringe barrel 154. In an embodiment, the operation of the syringe barrel 154 and plunger 156 can be reversed. For example, the plunger 156 can be fixedly engaged with the housing 130 to prevent any longitudinal movement relative thereto. The plunger 156 can be engaged with the housing 130 with an interference fit, snap-fit, press-fit engagement, adhesive, weld, bonding, or the like. The syringe barrel 154 can be supported by a barrel cradle 158. The barrel 154 and barrel cradle 158 assembly can be slidable relative to the plunger 156 and housing 130 assembly, and configured such that sliding the barrel 154 and cradle 158 assembly proximally can create a vacuum within the barrel 154. In an embodiment, the barrel cradle 158 can be formed of a transparent material to facilitate observing a blood flow therein.
Advantageously, reversing the operation of the blood flash indicator syringe barrel 154 and plunger 156 can further reduce the fluid path between the needle tip and the blood flash indicator 150. For example, as shown in
By contrast, as shown in
Advantageously, the action of the syringe barrel 154 and plunger 156 still allows a clinician to leverage the tactile and visual feedback offered via syringe-based blood flashback systems. Further, moving the syringe barrel 154 proximally moves the barrel 154 away from the distal end of the insertion device 100 providing a clearer line of sight at the insertion site and allows for additional operations to occur, for example the manipulation of guidewire advancement assemblies, catheter advancement assemblies, hinging housing portions, or the like.
In an embodiment, the barrel cradle 158 can include one or more gripping features 159 to facilitate grasping the syringe barrel 154 and urging the barrel 154 proximally. The gripping features 159 can include one or more abutments, finger loops, finger pad, ridges, ribs, or include materials having an increased friction co-efficient such rubber or silicone. In an embodiment, a portion of the blood flash channel 152, which provides fluid communication between the needle notch 118 and the syringe barrel 154, can include a flexible tube, or the like. Advantageously, the flexible tube can allow the syringe barrel 154 to slide proximally relative to the needle interface 140.
In an embodiment, as shown in
In use, the insertion system 200 can be advanced, until a needle tip 216 enters a vasculature of a patient. The plunger 256 can extend distally to allow a user to manipulate the plunger 256 while grasping a distal portion of the housing 230. Advancing the plunger 256 distally can create a vacuum within the syringe barrel 254 and draw a blood flow through the needle lumen to the needle notch, through a needle interface 240, through the blood flash channel and into the syringe barrel 254. As shown the syringe barrel 254 can be formed of a transparent material to facilitate observing a blood flow color and pulsatile flow. Advantageously, longitudinally aligning the proximal end of the syringe barrel 254 adjacent to the needle interface 240, the length of the blood flash channel can be reduced, further reducing the overall length of the blood flash fluid path.
While some particular embodiments have been disclosed herein, and while the particular embodiments have been disclosed in some detail, it is not the intention for the particular embodiments to limit the scope of the concepts provided herein. Additional adaptations and/or modifications can appear to those of ordinary skill in the art, and, in broader aspects, these adaptations and/or modifications are encompassed as well. Accordingly, departures may be made from the particular embodiments disclosed herein without departing from the scope of the concepts provided herein.
This application claims the benefit of priority to U.S. Provisional Application No. 63/128,677, filed Dec. 21, 2020, which is incorporated by reference in its entirety into this application.
Number | Name | Date | Kind |
---|---|---|---|
1013691 | Shields | Jan 1912 | A |
3225762 | Guttman | Dec 1965 | A |
3382872 | Rubin | May 1968 | A |
3570485 | Reilly | Mar 1971 | A |
3890976 | Bazell et al. | Jun 1975 | A |
4205675 | Vaillancourt | Jun 1980 | A |
4292970 | Hession, Jr. | Oct 1981 | A |
4468224 | Enzmann et al. | Aug 1984 | A |
4525157 | Vaillancourt | Jun 1985 | A |
4581019 | Curelaru et al. | Apr 1986 | A |
4594073 | Stine | Jun 1986 | A |
4702735 | Luther et al. | Oct 1987 | A |
4743265 | Whitehouse et al. | May 1988 | A |
4766908 | Clement | Aug 1988 | A |
4863432 | Kvalo | Sep 1989 | A |
4935008 | Lewis, Jr. | Jun 1990 | A |
4950252 | Luther et al. | Aug 1990 | A |
4994040 | Cameron et al. | Feb 1991 | A |
5017259 | Kohsai | May 1991 | A |
5040548 | Yock | Aug 1991 | A |
5057073 | Martin | Oct 1991 | A |
5112312 | Luther | May 1992 | A |
5115816 | Lee | May 1992 | A |
5120317 | Luther | Jun 1992 | A |
5158544 | Weinstein | Oct 1992 | A |
5188593 | Martin | Feb 1993 | A |
5195962 | Martin et al. | Mar 1993 | A |
5207650 | Martin | May 1993 | A |
RE34416 | Lemieux | Oct 1993 | E |
5267958 | Buchbinder et al. | Dec 1993 | A |
5295970 | Clinton et al. | Mar 1994 | A |
5306247 | Pfenninger | Apr 1994 | A |
5312361 | Zadini | May 1994 | A |
5322512 | Mohiuddin | Jun 1994 | A |
5328472 | Steinke et al. | Jul 1994 | A |
5350358 | Martin | Sep 1994 | A |
5358495 | Lynn | Oct 1994 | A |
5368567 | Lee | Nov 1994 | A |
5378230 | Mahurkar | Jan 1995 | A |
5380290 | Makower et al. | Jan 1995 | A |
5389087 | Miraki | Feb 1995 | A |
5439449 | Mapes et al. | Aug 1995 | A |
5443457 | Ginn et al. | Aug 1995 | A |
5460185 | Johnson et al. | Oct 1995 | A |
5489271 | Andersen | Feb 1996 | A |
5573520 | Schwartz et al. | Nov 1996 | A |
5683370 | Luther et al. | Nov 1997 | A |
5713876 | Bogert et al. | Feb 1998 | A |
5718678 | Fleming, III | Feb 1998 | A |
5772636 | Brimhall et al. | Jun 1998 | A |
5885251 | Luther | Mar 1999 | A |
5919164 | Andersen | Jul 1999 | A |
5921971 | Agro et al. | Jul 1999 | A |
5947940 | Beisel | Sep 1999 | A |
5957893 | Luther et al. | Sep 1999 | A |
5971957 | Luther et al. | Oct 1999 | A |
6159198 | Gardeski et al. | Dec 2000 | A |
6206849 | Martin et al. | Mar 2001 | B1 |
6228062 | Howell et al. | May 2001 | B1 |
6475187 | Gerberding | Nov 2002 | B1 |
6551284 | Greenberg et al. | Apr 2003 | B1 |
6606515 | Windheuser et al. | Aug 2003 | B1 |
6616630 | Woehr et al. | Sep 2003 | B1 |
6626869 | Bint | Sep 2003 | B1 |
6638252 | Moulton et al. | Oct 2003 | B2 |
6716228 | Tal | Apr 2004 | B2 |
6726659 | Stocking et al. | Apr 2004 | B1 |
6819951 | Patel et al. | Nov 2004 | B2 |
6821287 | Jang | Nov 2004 | B1 |
6926692 | Katoh et al. | Aug 2005 | B2 |
6962575 | Tal | Nov 2005 | B2 |
6991625 | Gately et al. | Jan 2006 | B1 |
6994693 | Tal | Feb 2006 | B2 |
6999809 | Currier et al. | Feb 2006 | B2 |
7025746 | Tal | Apr 2006 | B2 |
7029467 | Currier et al. | Apr 2006 | B2 |
7037293 | Carrillo et al. | May 2006 | B2 |
7074231 | Jang | Jul 2006 | B2 |
7094222 | Siekas | Aug 2006 | B1 |
7141050 | Deal et al. | Nov 2006 | B2 |
7144386 | Korkor et al. | Dec 2006 | B2 |
7311697 | Osborne | Dec 2007 | B2 |
7364566 | Elkins et al. | Apr 2008 | B2 |
7377910 | Katoh et al. | May 2008 | B2 |
7390323 | Jang | Jun 2008 | B2 |
D600793 | Bierman et al. | Sep 2009 | S |
D601242 | Bierman et al. | Sep 2009 | S |
D601243 | Bierman et al. | Sep 2009 | S |
7594911 | Powers et al. | Sep 2009 | B2 |
7691093 | Brimhall | Apr 2010 | B2 |
7722567 | Tal | May 2010 | B2 |
D617893 | Bierman et al. | Jun 2010 | S |
D624643 | Bierman et al. | Sep 2010 | S |
7819889 | Healy et al. | Oct 2010 | B2 |
7857788 | Racz | Dec 2010 | B2 |
D630729 | Bierman et al. | Jan 2011 | S |
7909797 | Kennedy, II et al. | Mar 2011 | B2 |
7909811 | Agro et al. | Mar 2011 | B2 |
7922696 | Tal et al. | Apr 2011 | B2 |
7938820 | Webster et al. | May 2011 | B2 |
7967834 | Tal et al. | Jun 2011 | B2 |
7976511 | Fojtik | Jul 2011 | B2 |
7985204 | Katoh et al. | Jul 2011 | B2 |
8073517 | Burchman | Dec 2011 | B1 |
8105286 | Anderson et al. | Jan 2012 | B2 |
8192402 | Anderson et al. | Jun 2012 | B2 |
8202251 | Bierman et al. | Jun 2012 | B2 |
8206356 | Katoh et al. | Jun 2012 | B2 |
8361011 | Mendels | Jan 2013 | B2 |
8372107 | Tupper | Feb 2013 | B2 |
8377006 | Tal et al. | Feb 2013 | B2 |
8454577 | Joergensen et al. | Jun 2013 | B2 |
8585858 | Kronfeld et al. | Nov 2013 | B2 |
8657790 | Tal et al. | Feb 2014 | B2 |
8672888 | Tal | Mar 2014 | B2 |
8696645 | Tal et al. | Apr 2014 | B2 |
8784362 | Boutilette et al. | Jul 2014 | B2 |
8827958 | Bierman et al. | Sep 2014 | B2 |
8876704 | Golden et al. | Nov 2014 | B2 |
8882713 | Call et al. | Nov 2014 | B1 |
8900192 | Anderson et al. | Dec 2014 | B2 |
8900207 | Uretsky | Dec 2014 | B2 |
8915884 | Tal et al. | Dec 2014 | B2 |
8956327 | Bierman et al. | Feb 2015 | B2 |
9023093 | Pal | May 2015 | B2 |
9067023 | Bertocci | Jun 2015 | B2 |
9126012 | McKinnon et al. | Sep 2015 | B2 |
9138252 | Bierman et al. | Sep 2015 | B2 |
9180275 | Helm | Nov 2015 | B2 |
9265920 | Rundquist et al. | Feb 2016 | B2 |
9272121 | Piccagli | Mar 2016 | B2 |
9445734 | Grunwald | Sep 2016 | B2 |
9522254 | Belson | Dec 2016 | B2 |
9554785 | Walters et al. | Jan 2017 | B2 |
9566087 | Bierman et al. | Feb 2017 | B2 |
9675784 | Belson | Jun 2017 | B2 |
9713695 | Bunch et al. | Jul 2017 | B2 |
9764117 | Bierman et al. | Sep 2017 | B2 |
9770573 | Golden et al. | Sep 2017 | B2 |
9814861 | Boutillette et al. | Nov 2017 | B2 |
9820845 | von Lehe et al. | Nov 2017 | B2 |
9861383 | Clark | Jan 2018 | B2 |
9872971 | Blanchard | Jan 2018 | B2 |
9884169 | Bierman et al. | Feb 2018 | B2 |
9889275 | Voss et al. | Feb 2018 | B2 |
9913585 | McCaffrey et al. | Mar 2018 | B2 |
9913962 | Tal et al. | Mar 2018 | B2 |
9981113 | Bierman | May 2018 | B2 |
10010312 | Tegels | Jul 2018 | B2 |
10065020 | Gaur | Sep 2018 | B2 |
10086170 | Chhikara et al. | Oct 2018 | B2 |
10098724 | Adams et al. | Oct 2018 | B2 |
10111683 | Tsamir et al. | Oct 2018 | B2 |
10118020 | Avneri et al. | Nov 2018 | B2 |
10130269 | McCaffrey et al. | Nov 2018 | B2 |
10220184 | Clark | Mar 2019 | B2 |
10220191 | Belson et al. | Mar 2019 | B2 |
10265508 | Baid | Apr 2019 | B2 |
10271873 | Steingisser et al. | Apr 2019 | B2 |
10376675 | Mitchell et al. | Aug 2019 | B2 |
10675440 | Abitabilo et al. | Jun 2020 | B2 |
10688281 | Blanchard et al. | Jun 2020 | B2 |
10806901 | Burkholz et al. | Oct 2020 | B2 |
10926060 | Stern et al. | Feb 2021 | B2 |
11260206 | Stone et al. | Mar 2022 | B2 |
11400260 | Huang et al. | Aug 2022 | B2 |
11759607 | Biancarelli | Sep 2023 | B1 |
20020040231 | Wysoki | Apr 2002 | A1 |
20020198492 | Miller et al. | Dec 2002 | A1 |
20030036712 | Heh et al. | Feb 2003 | A1 |
20030060863 | Dobak | Mar 2003 | A1 |
20030088212 | Tal | May 2003 | A1 |
20030100849 | Jang | May 2003 | A1 |
20030153874 | Tal | Aug 2003 | A1 |
20030158514 | Tal | Aug 2003 | A1 |
20040015138 | Currier et al. | Jan 2004 | A1 |
20040064086 | Gottlieb et al. | Apr 2004 | A1 |
20040116864 | Boudreaux | Jun 2004 | A1 |
20040116901 | Appling | Jun 2004 | A1 |
20040167478 | Mooney et al. | Aug 2004 | A1 |
20040193093 | Desmond | Sep 2004 | A1 |
20040230178 | Wu | Nov 2004 | A1 |
20050004554 | Osborne | Jan 2005 | A1 |
20050120523 | Schweikert | Jun 2005 | A1 |
20050131343 | Abrams et al. | Jun 2005 | A1 |
20050215956 | Nerney | Sep 2005 | A1 |
20050245882 | Elkins et al. | Nov 2005 | A1 |
20050283221 | Mann et al. | Dec 2005 | A1 |
20060009740 | Higgins et al. | Jan 2006 | A1 |
20060116629 | Tal et al. | Jun 2006 | A1 |
20060129100 | Tal | Jun 2006 | A1 |
20060129130 | Tal et al. | Jun 2006 | A1 |
20070276288 | Khaw | Nov 2007 | A1 |
20080045894 | Perchik et al. | Feb 2008 | A1 |
20080125744 | Treacy | May 2008 | A1 |
20080125748 | Patel | May 2008 | A1 |
20080132850 | Fumiyama et al. | Jun 2008 | A1 |
20080262430 | Anderson et al. | Oct 2008 | A1 |
20080262431 | Anderson et al. | Oct 2008 | A1 |
20080294111 | Tal et al. | Nov 2008 | A1 |
20080312578 | DeFonzo et al. | Dec 2008 | A1 |
20080319387 | Amisar et al. | Dec 2008 | A1 |
20090187147 | Kurth et al. | Jul 2009 | A1 |
20090221961 | Tal et al. | Sep 2009 | A1 |
20090270889 | Tal et al. | Oct 2009 | A1 |
20090292272 | McKinnon | Nov 2009 | A1 |
20100030154 | Duffy | Feb 2010 | A1 |
20100256487 | Hawkins et al. | Oct 2010 | A1 |
20100298839 | Castro | Nov 2010 | A1 |
20100305474 | DeMars et al. | Dec 2010 | A1 |
20110004162 | Tal | Jan 2011 | A1 |
20110009827 | Bierman et al. | Jan 2011 | A1 |
20110021994 | Anderson et al. | Jan 2011 | A1 |
20110066142 | Tal et al. | Mar 2011 | A1 |
20110071502 | Asai | Mar 2011 | A1 |
20110144620 | Tal | Jun 2011 | A1 |
20110152836 | Riopelle et al. | Jun 2011 | A1 |
20110190778 | Arpasi et al. | Aug 2011 | A1 |
20110202006 | Bierman et al. | Aug 2011 | A1 |
20110251559 | Tal et al. | Oct 2011 | A1 |
20110270192 | Anderson et al. | Nov 2011 | A1 |
20120041371 | Tal et al. | Feb 2012 | A1 |
20120065590 | Bierman et al. | Mar 2012 | A1 |
20120078231 | Hoshinouchi | Mar 2012 | A1 |
20120130411 | Tal et al. | May 2012 | A1 |
20120130415 | Tal et al. | May 2012 | A1 |
20120157854 | Kurrus et al. | Jun 2012 | A1 |
20120215171 | Christiansen | Aug 2012 | A1 |
20120220942 | Hall et al. | Aug 2012 | A1 |
20120226239 | Green | Sep 2012 | A1 |
20120283640 | Anderson et al. | Nov 2012 | A1 |
20120316500 | Bierman et al. | Dec 2012 | A1 |
20130053763 | Makino et al. | Feb 2013 | A1 |
20130053826 | Shevgoor | Feb 2013 | A1 |
20130123704 | Bierman et al. | May 2013 | A1 |
20130158338 | Kelly et al. | Jun 2013 | A1 |
20130188291 | Vardiman | Jul 2013 | A1 |
20130237931 | Tal et al. | Sep 2013 | A1 |
20130306079 | Tracy | Nov 2013 | A1 |
20140025036 | Bierman et al. | Jan 2014 | A1 |
20140081210 | Bierman et al. | Mar 2014 | A1 |
20140094774 | Blanchard | Apr 2014 | A1 |
20140100552 | Gallacher et al. | Apr 2014 | A1 |
20140207052 | Tal et al. | Jul 2014 | A1 |
20140207069 | Bierman et al. | Jul 2014 | A1 |
20140214005 | Belson | Jul 2014 | A1 |
20140257111 | Yamashita et al. | Sep 2014 | A1 |
20140276432 | Bierman et al. | Sep 2014 | A1 |
20140276599 | Cully et al. | Sep 2014 | A1 |
20150011834 | Ayala et al. | Jan 2015 | A1 |
20150080939 | Adams et al. | Mar 2015 | A1 |
20150094653 | Pacheco et al. | Apr 2015 | A1 |
20150112307 | Margolis | Apr 2015 | A1 |
20150112310 | Call et al. | Apr 2015 | A1 |
20150126930 | Bierman et al. | May 2015 | A1 |
20150148595 | Bagwell et al. | May 2015 | A1 |
20150190168 | Bierman et al. | Jul 2015 | A1 |
20150196210 | McCaffrey et al. | Jul 2015 | A1 |
20150224287 | Bian et al. | Aug 2015 | A1 |
20150231364 | Blanchard et al. | Aug 2015 | A1 |
20150283357 | Lampropoulos et al. | Oct 2015 | A1 |
20150297868 | Tal et al. | Oct 2015 | A1 |
20150320969 | Haslinger et al. | Nov 2015 | A1 |
20150320977 | Vitullo et al. | Nov 2015 | A1 |
20150351793 | Bierman et al. | Dec 2015 | A1 |
20150359549 | Lenker et al. | Dec 2015 | A1 |
20150359998 | Carmel et al. | Dec 2015 | A1 |
20160082223 | Barnell | Mar 2016 | A1 |
20160114124 | Tal | Apr 2016 | A1 |
20160158523 | Helm | Jun 2016 | A1 |
20160220786 | Mitchell et al. | Aug 2016 | A1 |
20160242661 | Fischell et al. | Aug 2016 | A1 |
20160256101 | Aharoni et al. | Sep 2016 | A1 |
20160325073 | Davies et al. | Nov 2016 | A1 |
20160331938 | Blanchard et al. | Nov 2016 | A1 |
20160338728 | Tal | Nov 2016 | A1 |
20160346503 | Jackson et al. | Dec 2016 | A1 |
20170035990 | Swift | Feb 2017 | A1 |
20170072165 | Lim et al. | Mar 2017 | A1 |
20170120000 | Osypka et al. | May 2017 | A1 |
20170120014 | Harding et al. | May 2017 | A1 |
20170120034 | Kaczorowski | May 2017 | A1 |
20170128700 | Roche Rebollo | May 2017 | A1 |
20170156987 | Babbs et al. | Jun 2017 | A1 |
20170172653 | Urbanski et al. | Jun 2017 | A1 |
20170182293 | Chhikara | Jun 2017 | A1 |
20170239443 | Abitabilo et al. | Aug 2017 | A1 |
20170259043 | Chan et al. | Sep 2017 | A1 |
20170273713 | Shah et al. | Sep 2017 | A1 |
20170296792 | Ornelas Vargas et al. | Oct 2017 | A1 |
20170326339 | Bailey et al. | Nov 2017 | A1 |
20170361070 | Hivert | Dec 2017 | A1 |
20170368255 | Provost et al. | Dec 2017 | A1 |
20180001062 | O'Carrol et al. | Jan 2018 | A1 |
20180021545 | Mitchell et al. | Jan 2018 | A1 |
20180116690 | Sarabia et al. | May 2018 | A1 |
20180117284 | Appling et al. | May 2018 | A1 |
20180133438 | Hulvershorn et al. | May 2018 | A1 |
20180154062 | DeFonzo et al. | Jun 2018 | A1 |
20180154112 | Chan et al. | Jun 2018 | A1 |
20180214674 | Ebnet et al. | Aug 2018 | A1 |
20180296799 | Horst et al. | Oct 2018 | A1 |
20180296804 | Bierman | Oct 2018 | A1 |
20180310955 | Lindekugel et al. | Nov 2018 | A1 |
20190015646 | Matlock et al. | Jan 2019 | A1 |
20190021640 | Burkholz et al. | Jan 2019 | A1 |
20190060616 | Solomon | Feb 2019 | A1 |
20190076167 | Fantuzzi et al. | Mar 2019 | A1 |
20190134349 | Cohn et al. | May 2019 | A1 |
20190192824 | Cordeiro et al. | Jun 2019 | A1 |
20190201665 | Turpin | Jul 2019 | A1 |
20190209812 | Burkholz et al. | Jul 2019 | A1 |
20190255294 | Mitchell et al. | Aug 2019 | A1 |
20190255298 | Mitchell et al. | Aug 2019 | A1 |
20190275303 | Tran et al. | Sep 2019 | A1 |
20190276268 | Akingba | Sep 2019 | A1 |
20190321590 | Burkholz et al. | Oct 2019 | A1 |
20190351196 | Ribelin et al. | Nov 2019 | A1 |
20200001051 | Huang et al. | Jan 2020 | A1 |
20200016374 | Burkholz et al. | Jan 2020 | A1 |
20200046948 | Burkholz et al. | Feb 2020 | A1 |
20200100716 | Devgon et al. | Apr 2020 | A1 |
20200129732 | Vogt et al. | Apr 2020 | A1 |
20200147349 | Holt | May 2020 | A1 |
20200197682 | Franklin et al. | Jun 2020 | A1 |
20200197684 | Wax | Jun 2020 | A1 |
20200237278 | Asbaghi | Jul 2020 | A1 |
20200359995 | Walsh et al. | Nov 2020 | A1 |
20210030944 | Cushen et al. | Feb 2021 | A1 |
20210060306 | Kumar | Mar 2021 | A1 |
20210069471 | Howell | Mar 2021 | A1 |
20210085927 | Howell | Mar 2021 | A1 |
20210100985 | Akcay et al. | Apr 2021 | A1 |
20210113809 | Howell | Apr 2021 | A1 |
20210113810 | Howell | Apr 2021 | A1 |
20210113816 | DiCianni | Apr 2021 | A1 |
20210121661 | Howell | Apr 2021 | A1 |
20210121667 | Howell | Apr 2021 | A1 |
20210228842 | Scherich et al. | Jul 2021 | A1 |
20210228843 | Howell et al. | Jul 2021 | A1 |
20210244920 | Kujawa et al. | Aug 2021 | A1 |
20210290898 | Burkholz | Sep 2021 | A1 |
20210290901 | Burkholz et al. | Sep 2021 | A1 |
20210290913 | Horst et al. | Sep 2021 | A1 |
20210322729 | Howell | Oct 2021 | A1 |
20210330941 | Howell et al. | Oct 2021 | A1 |
20210330942 | Howell | Oct 2021 | A1 |
20210361915 | Howell et al. | Nov 2021 | A1 |
20210402149 | Howell | Dec 2021 | A1 |
20210402153 | Howell et al. | Dec 2021 | A1 |
20220001138 | Howell | Jan 2022 | A1 |
20220032013 | Howell et al. | Feb 2022 | A1 |
20220032014 | Howell et al. | Feb 2022 | A1 |
20220062528 | Thornley et al. | Mar 2022 | A1 |
20220062596 | Ribelin et al. | Mar 2022 | A1 |
20220126064 | Tobin et al. | Apr 2022 | A1 |
20220193376 | Spataro et al. | Jun 2022 | A1 |
20220193377 | Haymond et al. | Jun 2022 | A1 |
20220323723 | Spataro et al. | Oct 2022 | A1 |
20220331562 | Jaros et al. | Oct 2022 | A1 |
20220331563 | Papadia | Oct 2022 | A1 |
20230042898 | Howell et al. | Feb 2023 | A1 |
20230096377 | West et al. | Mar 2023 | A1 |
20230096740 | Bechstein et al. | Mar 2023 | A1 |
20230099654 | Blanchard et al. | Mar 2023 | A1 |
20230100482 | Howell | Mar 2023 | A1 |
20230101455 | Howell et al. | Mar 2023 | A1 |
20230102231 | Bechstein et al. | Mar 2023 | A1 |
20230173231 | Parikh et al. | Jun 2023 | A1 |
20230233814 | Howell et al. | Jul 2023 | A1 |
20230381459 | Belson et al. | Nov 2023 | A1 |
20240009427 | Howell et al. | Jan 2024 | A1 |
20240050706 | Howell et al. | Feb 2024 | A1 |
20240198058 | Howell et al. | Jun 2024 | A1 |
20250001136 | Mitchell et al. | Jan 2025 | A1 |
Number | Date | Country |
---|---|---|
202012006191 | Jul 2012 | DE |
0653220 | May 1995 | EP |
0730880 | Sep 1996 | EP |
2061385 | May 2009 | EP |
1458437 | Mar 2010 | EP |
2248549 | Nov 2010 | EP |
2319576 | May 2011 | EP |
2366422 | Sep 2011 | EP |
2486880 | Aug 2012 | EP |
2486881 | Aug 2012 | EP |
2486951 | Aug 2012 | EP |
2512576 | Oct 2012 | EP |
2152348 | Feb 2015 | EP |
3473291 | Apr 2019 | EP |
3093038 | May 2019 | EP |
2260897 | Sep 2019 | EP |
3693051 | Aug 2020 | EP |
1273547 | May 1972 | GB |
2004248987 | Sep 2004 | JP |
2008054859 | Mar 2008 | JP |
9421315 | Sep 1994 | WO |
9532009 | Nov 1995 | WO |
9844979 | Oct 1998 | WO |
9853871 | Dec 1998 | WO |
9857685 | Dec 1998 | WO |
9912600 | Mar 1999 | WO |
9926681 | Jun 1999 | WO |
0006221 | Feb 2000 | WO |
0054830 | Sep 2000 | WO |
2003008020 | Jan 2003 | WO |
2003057272 | Jul 2003 | WO |
03068073 | Aug 2003 | WO |
2003066125 | Aug 2003 | WO |
2005096778 | Oct 2005 | WO |
2006055288 | May 2006 | WO |
2006055780 | May 2006 | WO |
2007046850 | Apr 2007 | WO |
2008033983 | Mar 2008 | WO |
2008092029 | Jul 2008 | WO |
2008131300 | Oct 2008 | WO |
2008131289 | Oct 2008 | WO |
2009114833 | Sep 2009 | WO |
2009114837 | Sep 2009 | WO |
2010048449 | Apr 2010 | WO |
2010056906 | May 2010 | WO |
2010083467 | Jul 2010 | WO |
2010132608 | Nov 2010 | WO |
2011081859 | Jul 2011 | WO |
2011097639 | Aug 2011 | WO |
2011109792 | Sep 2011 | WO |
2011146764 | Nov 2011 | WO |
2012068162 | May 2012 | WO |
2012068166 | May 2012 | WO |
2012135761 | Oct 2012 | WO |
2012154277 | Nov 2012 | WO |
2012162677 | Nov 2012 | WO |
2013026045 | Feb 2013 | WO |
2013138519 | Sep 2013 | WO |
2014006403 | Jan 2014 | WO |
2014100392 | Jun 2014 | WO |
2014113257 | Jul 2014 | WO |
2014152005 | Sep 2014 | WO |
2014197614 | Dec 2014 | WO |
2015057766 | Apr 2015 | WO |
2015077560 | May 2015 | WO |
2015168655 | Nov 2015 | WO |
2016110824 | Jul 2016 | WO |
2016123278 | Aug 2016 | WO |
2016139590 | Sep 2016 | WO |
2016139597 | Sep 2016 | WO |
2016178974 | Nov 2016 | WO |
2016187063 | Nov 2016 | WO |
2016176065 | Nov 2016 | WO |
2018089275 | May 2018 | WO |
2018089285 | May 2018 | WO |
2018089385 | May 2018 | WO |
2018191547 | Oct 2018 | WO |
2018213148 | Nov 2018 | WO |
2018218236 | Nov 2018 | WO |
2019050576 | Mar 2019 | WO |
2019146026 | Aug 2019 | WO |
2019199734 | Oct 2019 | WO |
2020014149 | Jan 2020 | WO |
2020069395 | Apr 2020 | WO |
2020109448 | Jun 2020 | WO |
2020113123 | Jun 2020 | WO |
2021038041 | Mar 2021 | WO |
2021050302 | Mar 2021 | WO |
2021077103 | Apr 2021 | WO |
2021062023 | Apr 2021 | WO |
2021081205 | Apr 2021 | WO |
2021086793 | May 2021 | WO |
2021236950 | Nov 2021 | WO |
2021226050 | Nov 2021 | WO |
2022031618 | Feb 2022 | WO |
2022094141 | May 2022 | WO |
2022133297 | Jun 2022 | WO |
2022-140406 | Jun 2022 | WO |
2022140429 | Jun 2022 | WO |
2022217098 | Oct 2022 | WO |
2023014994 | Feb 2023 | WO |
2023049498 | Mar 2023 | WO |
2023049505 | Mar 2023 | WO |
2023049511 | Mar 2023 | WO |
2023049519 | Mar 2023 | WO |
2023049522 | Mar 2023 | WO |
2023146792 | Aug 2023 | WO |
Entry |
---|
PCT/US2022/039614 filed Aug. 5, 2022 International Search Report and Written Opinion dated Dec. 22, 2022. |
PCT/US2022/044848 filed Sep. 27, 2022 International Search Report and Written Opinion dated Feb. 3, 2023. |
PCT/US2022/044879 filed Sep. 27, 2022 International Search Report and Written Opinion dated Mar. 3, 2023. |
PCT/US2022/044901 filed Sep. 27, 2022 International Search Report and Written Opinion dated Mar. 3, 2023. |
PCT/US2022/044918 filed Sep. 27, 2022 International Search Report and Written Opinion dated Feb. 21, 2023. |
PCT/US2022/044923 filed Sep. 27, 2022 International Search Report and Written Opinion dated Feb. 15, 2023. |
U.S. Appl. No. 17/156,252, filed Jan. 22, 2021 Notice of Allowance dated Apr. 24, 2023. |
U.S. Appl. No. 17/237,909, filed Apr. 22, 2021 Restriction Requirement dated Feb. 1, 2023. |
U.S. Appl. No. 17/326,017, filed May 20, 2021 Non-Final Office Action dated Jan. 26, 2023. |
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Non-Final Office Action dated Mar. 2, 2023. |
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Restriction Requirement dated Mar. 30, 2023. |
PCT/US2020/052536 filed Sep. 24, 2020 International Search Report and Written Opinion dated Dec. 4, 2020. |
PCT/US2021/014700 filed Jan. 22, 2021 International Search Report and Written Opinion dated Jun. 29, 2021. |
PCT/US2021/028018 filed Apr. 19, 2021 International Search Report and Written Opinion dated Sep. 13, 2021. |
PCT/US2021/028683 filed Apr. 22, 2021 International Search Report and Written Opinion dated Sep. 16, 2021. |
PCT/US2021/029183 filed Apr. 26, 2021 International Search Report and Written Opinion dated Sep. 24, 2021. |
PCT/US2021/033443 filed May 20, 2021 International Search Report and Written Opinion dated Sep. 23, 2021. |
PCT/US2021/039084 filed Jun. 25, 2021 International Search Report and Written Opinion dated Jan. 10, 2022. |
PCT/US2021/044029 filed Jul. 30, 2021 International Search Report and Written Opinion dated Dec. 9, 2021. |
PCT/US2021/044223 filed Aug. 2, 2021 International Search Report and Written Opinion dated Dec. 21, 2021. |
PCT/US2021/048275 filed Aug. 30, 2021 International Search Report and Written Opinion dated Jan. 4, 2022. |
U.S. Appl. No. 15/008,628, filed Jan. 28, 2016 Final Office Action dated May 30, 2018. |
U.S. Appl. No. 15/008,628, filed Jan. 28, 2016 Non-Final Office Action dated Jan. 25, 2019. |
U.S. Appl. No. 15/008,628, filed Jan. 28, 2016 Non-Final Office Action dated Nov. 2, 2017. |
U.S. Appl. No. 15/008,628, filed Jan. 28, 2016 Notice of Allowance dated May 15, 2019. |
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Final Office Action dated Jan. 25, 2022. |
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Non-Final Office Action dated May 11, 2021. |
U.S. Appl. No. 17/031,478, filed Sep. 24, 2020 Non-Final Office Action dated May 11, 2022. |
PCT/US2021/057135 filed Oct. 28, 2021 International Preliminary Report on Patentability dated May 2, 2023. |
PCT/US2021/057135 filed Oct. 28, 2021 International Search Report and Written Opinion dated Mar. 11, 2022. |
PCT/US2023/011173 filed Jan. 19, 2023 International Search Report and Written Opinion dated May 22, 2023. |
U.S. Appl. No. 17/240,591, filed Apr. 26, 2021 Non-Final Office Action dated Jun. 8, 2023. |
U.S. Appl. No. 17/326,017, filed May 20, 2021 Notice of Allowance dated Jul. 3, 2023. |
U.S. Appl. No. 17/358,504, filed Jun. 25, 2021 Restriction Requirement dated Jun. 7, 2023. |
U.S. Appl. No. 17/360,694, filed Jun. 28, 2021 Restriction Requirement dated Jul. 20, 2023. |
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Non-Final Office Action dated Jul. 17, 2023. |
PCT/US2021/028018 filed Apr. 19, 2021 International Preliminary Report on Patentability dated Jun. 3, 2022. |
PCT/US2021/064174 filed Dec. 17, 2021 International Search Report and Written Opinion dated May 18, 2022. |
PCT/US2021/064642 filed Dec. 21, 2021 International Search Report and Written Opinion dated May 11, 2022. |
PCT/US2021/064671 filed Dec. 21, 2021 International Search Report and Written Opinion dated May 27, 2022. |
PCT/US2022/024085 filed Apr. 8, 2022 International Search Report and Wirtten Opinion dated Sep. 12, 2022. |
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Examiner's Answer dated Oct. 31, 2022. |
U.S. Appl. No. 17/031,478, filed Sep. 24, 2020 Notice of Allowance dated Sep. 16, 2022. |
U.S. Appl. No. 17/156,252, filed Jan. 22, 2021 Non-Final Office Action dated Oct. 25, 2022. |
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Board Decision dated Oct. 30, 2023. |
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Non-Final Office Action dated Jan. 18, 2024. |
U.S. Appl. No. 17/234,611, filed Apr. 19, 2021 Restriction Requirement dated Jan. 18, 2024. |
U.S. Appl. No. 17/237,909, filed Apr. 22, 2021 Notice of Allowance dated Oct. 27, 2023. |
U.S. Appl. No. 17/240,591, filed Apr. 26, 2021 Final Office Action dated Dec. 6, 2023. |
U.S. Appl. No. 17/360,694, filed Jun. 28, 2021 Non-Final Office Action dated Feb. 14, 2024. |
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Non-Final Office Action dated Dec. 1, 2023. |
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Advisory Action dated Feb. 14, 2024. |
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Final Office Action dated Nov. 21, 2023. |
U.S. Appl. No. 17/513,789, filed Oct. 28, 2021 Non-Final Office Action dated Jan. 9, 2024. |
U.S. Appl. No. 17/234,611, filed Apr. 19, 2021 Non-Final Office Action dated Apr. 23, 2024. |
U.S. Appl. No. 17/240,591, filed Apr. 26, 2021 Advisory Action dated Feb. 22, 2024. |
U.S. Appl. No. 17/358,504, filed Jun. 25, 2021 Final Office Action dated Mar. 13, 2024. |
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Final Office Action dated May 6, 2024. |
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Non-Final Office Action dated Apr. 23, 2024. |
U.S. Appl. No. 17/554,978, filed Dec. 17, 2021 Non-Final Office Action dated Apr. 19, 2024. |
U.S. Appl. No. 17/156,252, filed Jan. 22, 2021 Notice of Allowance dated Aug. 9, 2023. |
U.S. Appl. No. 17/237,909, filed Apr. 22, 2021 Non-Final Office Action dated Jul. 27, 2023. |
U.S. Appl. No. 17/358,504, filed Jun. 25, 2021 Non-Final Office Action dated Oct. 4, 2023. |
U.S. Appl. No. 17/360,694, filed Jun. 28, 2021 Non-Final Office Action dated Oct. 13, 2023. |
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Final Office Action dated Jul. 27, 2023. |
U.S. Appl. No. 17/513,789, filed Oct. 28, 2021 Restriction Requirement dated Oct. 3, 2023. |
U.S. Appl. No. 17/234,611, filed Apr. 19, 2021 Final Office Action dated Sep. 20, 2024. |
U.S. Appl. No. 17/240,591, filed Apr. 26, 2021 Final Office Action dated Aug. 14, 2024. |
U.S. Appl. No. 17/558,124, filed Dec. 21, 2021 Non-Final Office Action dated Sep. 20, 2024. |
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Notice of Allowance dated May 20, 2024. |
U.S. Appl. No. 17/240,591, filed Apr. 26, 2021 Non-Final Office Action dated Jun. 4, 2024. |
U.S. Appl. No. 17/358,504, filed Jun. 25, 2021 Notice of Allowance dated Jul. 17, 2024. |
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Non-Final Office Action dated Jul. 5, 2024. |
U.S. Appl. No. 17/513,789, filed Oct. 28, 2021 Final Office Action dated Jul. 9, 2024. |
U.S. Appl. No. 17/554,978, filed Dec. 17, 2021 Notice of Allowance dated Jul. 24, 2024. |
U.S. Appl. No. 17/360,694, filed Jun. 28, 2021 Notice of Allowance dated Dec. 16, 2024. |
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Final Office Action dated Jan. 2, 2025. |
U.S. Appl. No. 17/461,619, filed Aug. 30, 2021 Restriction Requirement dated Dec. 6, 2024. |
U.S. Appl. No. 17/513,789, filed Oct. 28, 2021 Notice of Allowance dated Jan. 3, 2025. |
Number | Date | Country | |
---|---|---|---|
20220193378 A1 | Jun 2022 | US |
Number | Date | Country | |
---|---|---|---|
63128677 | Dec 2020 | US |